LOS ANGELES CALIFORNIA, August 25, 2023 (GLOBE NEWSWIRE) — MetAlert, Inc. (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology for remote patient monitoring, announces a collaboration with the Next Realm AI Research Lab, an artificial intelligence and data analytics research center located in New York. This alliance involves MetAlert providing invaluable data from its current wearable technology suite to fuel Next Realm AI’s research projects. Moreover, MetAlert will offer its expertise, guiding the best methods to harness this data, primarily focusing on location-centric healthcare technology. This partnership aims to sculpt the blueprint for predictive models within the ever evolving and growing to an estimated $62 billion by 2025 wearable health tech sector; and will focus on developing the framework for predictive health models utilizing data securely and privately aggregated from wearable tech devices.
Tom Bustamante, the Founder & CEO of Next Realm AI, shared his excitement, stating, “Collaborating with MetAlert, a brand synonymous with wearable technology and real-time data, represents a big leap towards our shared vision to find predictive patterns that may lead to earlier disease detection, bespoke treatments and eventually, offering a more personalized approach to prolonged, high-quality health.”
Patrick Bertagna, the CEO of MetAlert, weighed in: “Post the global pandemic, we’ve been exploring avenues to help improve and extend quality of life. In this pursuit, AI is seemingly becoming a critical component, but to realize AI’s true potential, we need data. We believe data is this era’s new oil, and wearable technology is the invaluable vessel that can collect this data in real-time across the globe.”
As an official IBM Business Partner, Next Realm AI helps lab members integrate leading-edge AI and data solutions into their business operations. By leveraging Next Realm’s expertise, clients can modernize processes, boost efficiency, strengthen security, and deliver greater value to customers – all while driving growth and building value for shareholders. www.nextrealm.ai
To find out more please contact info@metalert.com business development.
MetAlert (OTC: MLRT) and its subsidiaries occupy a commanding position in the design, development, manufacturing, distribution, sales, and licensing of GPS wearable technology, asset recovery services, wandering assistive technology, and health data collection and monitoring. The Company delivers comprehensive global solutions encompassing logistics, hardware, software, and connectivity.
Notable achievements include GunAlert the world’s first all in one firearm safety solution gun lock with patented motion sensor and GPS theft recovery. And the groundbreaking GPS SmartSole®, a fusion of Dr. Scholl’s comfort with LoJack’s tracking prowess. It stands as the world’s inaugural invisible wearable tracking device, designed for individuals susceptible to wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury. MetAlert’s subscription-based model thrives on technology innovation fortified by intellectual property safeguards. The company boasts international distribution channels serving customers across 40 countries, alongside its role as a U.S. Military Government contractor. In addition to public health entities, MetAlert caters to municipalities, emergency and law enforcement agencies, private educational institutions, assisted living facilities, NGOs, senior care residences, consumers, and small enterprises.
General information, investor relations, wholesale licensing, consumer purchase:
213.489.3019 | Info@MetAlert.com | IR@MetAlert.com | Contact Us
MetAlert.com | Mygunalert.com | Track My Workforce | GPS SmartSole.com
MetAlert United Kingdom– In the UK, MetAlert operates from its London office.
Please contact: Nelson Skip Riddle | Email: NSRiddle@MetAlert.com | Tel: +44 7785 364100
Level 2 Security (Wholly owned subsidiary) Email: contactus@level2sec.com | www.mygunalert.com | www.ifitmoves.com
Forward Looking Statements
This news release contains forward-looking statements. The terms and phrases “expects,” “would,” “will,” “believes,” and similar terms and phrases are intended to identify these forward-looking statements. Forward-looking statements are based on estimates and assumptions made by MetAlert considering its experience and perception of current conditions and expected future developments, as well as other factors that MetAlert believes are appropriate in the circumstances. Many factors could cause MetAlert’s actual results, performance, or achievements to differ materially from those expressed or implied by the forward-looking statements. Certain risk factors that may cause actual results to differ are outlined in MetAlert’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (which may be obtained on the SEC Website). These factors should be considered carefully, and readers should not rely on MetAlert’s forward-looking statements. MetAlert has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required.
Disclaimer: MetAlert does not warrant or represent that the unauthorized use of materials drawn from this document’s content will not infringe the rights of third parties who are not owned or affiliated by MetAlert. Further, MetAlert cannot be held responsible or liable for the unauthorized use of this document’s content by third parties unknown to the company.